The role of MEOX1 in non-neoplastic and neoplastic diseases

Biomed Pharmacother. 2023 Feb:158:114068. doi: 10.1016/j.biopha.2022.114068. Epub 2022 Dec 7.

Abstract

Targeted gene therapy has shown durable efficacy in non-neoplastic and neoplastic patients. Therefore, finding a suitable target has become a key area of research. Mesenchyme homeobox 1 (MEOX1) is a transcriptional factor that plays a significant role in regulation of somite development. Evidence indicates that abnormalities in MEOX1 expression and function are associated with a variety of pathologies, including non-neoplastic and neoplastic diseases. MEOX1 expression is upregulated during progression of most diseases and plays a critical role in maintenance of the cellular phenotypes such as cell differentiation, cell cycle arrest and senescence, migration, and proliferation. Therefore, MEOX1 may become an important molecular target and therapeutic target. This review will discuss the current state of knowledge on the role of MEOX1 in different diseases.

Keywords: Cellular phenotype; Disease progression; MEOX1; Therapeutic target; Upregulated gene.

Publication types

  • Review

MeSH terms

  • Cell Differentiation
  • Cellular Senescence
  • Gene Expression Regulation
  • Gene Expression Regulation, Neoplastic
  • Homeodomain Proteins* / genetics
  • Homeodomain Proteins* / metabolism
  • Humans
  • Neoplasms* / genetics
  • Transcription Factors / metabolism

Substances

  • Homeodomain Proteins
  • Transcription Factors
  • MEOX1 protein, human